Relationship between symptom dimensions and white matter alterations in obsessive-compulsive disorder.
Yagi M, Hirano Y, Nakazato M, Nemoto K, Ishikawa K, Sutoh C, Miyata H, Matsumoto J, Matsumoto K, Masuda Y, Obata T, Iyo M, Shimizu E, Nakagawa A.
Yagi M, et al. Among authors: masuda y.
Acta Neuropsychiatr. 2017 Jun;29(3):153-163. doi: 10.1017/neu.2016.45. Epub 2016 Sep 13.
Acta Neuropsychiatr. 2017.
PMID: 27620171
Clinical Trial.